TickerFacts.

InMed Pharmaceuticals Inc. (INM): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Older than the company's other figures. The latest EBITDA is for the year ended 2023-06-30, while the company's latest annual report covers the year ended 2026-06-30. Its later filings do not report Operating Income, which EBITDA is computed from, under the concepts TickerFacts maps.

-$7.75M
Year ended 2023-06-30
2021-06-30: -$10.08M2022-06-30: -$18.41M2023-06-30: -$7.75M-$7.75M
2021-06-30 EBITDA (USD) 2023-06-30
Period endedEBITDAChange YoYSource filing
2023-06-30-$7.75Mn/m2024-09-30, From 2022-07-01
2022-06-30-$18.41Mn/m2023-09-29, From 2021-07-01
2021-06-30-$10.08Mn/a2022-09-23, From 2020-07-01